Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
activist, Agilux, agrochemical, alleviate, answer, antitrust, aquatic, article, Barbo, binding, BioMotiv, biosimilar, Blue, Brexit, check, Clarifying, congressional, delinquent, denying, deployed, divergent, dose, dystrophy, editing, expressly, filer, floor, Genentech, genome, genotype, GMP, Harrington, hosting, instrument, inter, IPR, juvenile, leadership, London, longstanding, mark, member, membership, modestly, morphometry, myotonic, nonredeemable, oral, par, pattern, Pharma, power, prepayment, presidential, QS, Quotient, realignment, redemption, referendum, reinforce, reinforced, Renminbi, replicate, Roche, seasoned, shell, softer, solid, stereology, Stream, technician, terrestrial, Trademark, unconditional, William, Yuan
Removed:
accelerating, ACVP, addressed, aggregated, announced, anticipating, appraised, arbitration, Asian, bond, calculating, caption, certified, convertible, deductibility, deduction, delivering, detriment, discrete, EMD, exchanged, favor, franchise, Gillett, intensified, joint, launch, manager, match, modernizing, Nancy, nasdaq, nondeductible, partnership, pathologist, preclinical, predecessor, requesting, reviewing, Sierra, Southeast, visible
Filing tables
Filing exhibits
Related press release
CRL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3ASR (No. 333-205954) and Forms S-8 (No. 333-212507, No. 333-190292, No. 333-174971, No. 333-161024, No. 333-144177, No. 333-124853, No. 333-105803, No. 333-61336 and No. 333-47768) of Charles River Laboratories International, Inc. of our report dated February 14, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 14, 2017